None listed
Conditions
Interventions
investigational material(s)
Generic name etc : Migsis Tablets
INN of investigational material :
Therapeutic category code : 219 Other cardiovascular agents
Dosage and Administration for Investigation
Sponsors
LSI Medience Corporation
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: The weight (kg) / height (m) 2 :18.5 or more and less than 25.0 at the time of a prior inspection. There is consent to clinical test participation. Nationality Japanese
Exclusion criteria
Exclusion criteria: 1.A person who had shown symptoms of allergy caused by this test drug or its composition. 2.A person who is suffering from Intracranial hemorrhage, cerebral infarction, liver disease, Parkinson's disease, depression and who is suspected to have these diseases. 3.A history of alcohol or drug addiction, 4.Under the medical treatment or it may treat of a certain disease, 5.Ethical or OTC pharmaceuticals administered within two weeks before scheduled administration of the study drug, Supplement, grapefruit or its products, or foods coating Western St. John's consumed within one week before scheduled administration of the study drug. 6.Not less than 200mL of blood is collected within 30 days or not less than 400mL of blood is collected within 90 days before scheduled administration of the study drug. 7.Weight: less than 50kg (at the time of a prior inspection), 8.A person shall not have a schedule of consultation of another hospital until this administration study. 9.A person judged unfit of this study by responsible doctor
Outcome results
None listed